Page 2 - Vitro Diagnostics Software News Today

SEOUL, South Korea (PRWEB) May 13, 2022 -- Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software, announced that the

SEOUL, South Korea (PRWEB) April 11, 2022 -- Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, presented five abstracts in regards to

Seoul, Korea, March 23, 2022 (PRWEB) March 23, 2022 -- Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced five research studies

SEOUL, South Korea (PRWEB) November 30, 2021 -- Deep Bio, a leading AI biotech dedicated to cancer diagnosis, announced that it has entered into a

Seoul, South Korea (PRWEB) November 24, 2021 -- Deep Bio, a pioneer in medical AI specialized for cancer diagnostics, announced that it has received Korea

SEOUL, South Korea (PRWEB) October 28, 2021 -- Deep Bio, a pioneer in medical AI specialized for cancer diagnostics, announced a strategic relationship with a

SEOUL, South Korea (PRWEB) October 18, 2021 -- Deep Bio, a pioneer in medical AI specialized for cancer diagnostics, announced that new study results on

GENEVA, Switzerland (PRWEB) October 18, 2021 -- Healthcare Konnect, a Swiss medical device distribution company, and Deep Bio Inc., a South Korean leader in

SEOUL, South Korea (PRWEB) August 13, 2021 -- Deep Bio, a leading AI biotech dedicated to pathologic cancer diagnosis and prognosis, announced an on-going

SEOUL, South Korea, July 23, 2021 /PRNewswire-PRWeb/ — Deep Bio, a leading company in digital pathology and cancer diagnostics, today announced a renewal of their Research Collaboration Agreement with Dana-Farber Cancer Institute aimed at evaluating prostate cancer tumors. This collaboration with Dana-Farber is a part of the Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium, a global collaboration formed to evaluate the high burden of prostate cancer in the Sub-Saharan...